Department of Health and Human Services' logo Department of Health and Human Services

Public Health Service
Food and Drug Administration

 

5100 Paint Branch Pkwy
College Park, MD 20740-3835

Mar 1, 2005

Warning Letter

Certified Mail

Return Receipt Requested

USA Chemicals, Inc.
P.O. Box 4195
Cordova, TN 38088

Perry M. Belcher Companies
P.O. Box 3795
Cordova, TN 38088-3795

Dear Sir or Madam:

This is to advise you that the Food and Drug Administration (FDA) has reviewed your web sites at the Internet addresses http://www.schmedica.com, http://www.welatonin.com, http://www.tanningpillsplus.com and http://veinocal.com and has determined that your products Welatonin™, Digestrin™, Veinocal™, Chitorex™, Goutin™, and Canthorex™ are promoted for conditions that cause the products to be drugs under section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. 321(g)(1)(B)]. The therapeutic claims on your web site establish that the products are drugs because they are intended for use in the cure, mitigation, treatment, or prevention of disease. The marketing of these products with these claims violates the Act.

Examples of some of the claims observed on your web site include:

Welatonin™

Digestrin™

Veinocal™

Chitorex™

Goutin™

Canthorex™

FDA has no information that your products are generally recognized as safe and effective for the above reference conditions and therefore, these products may also be "new drugs" under section 201(p) of the Act [21 U.S.C. 321(p)]. New drugs may not be legally marketed in the U.S. without prior approval form FDA as described in section 505(a) of the Act [21 U.S.C 355(a)]. FDA approves new drugs on the basis of scientific data submitted by a drug sponsor to demonstrate that the drugs are safe and effective.

Even if your products did not bear disease claims that cause them to be drugs, as dietary supplements, they are misbranded. Under the Act, as amended by the Dietary Supplement Health and Education Act, dietary supplements may be legally marketed with claims to affect the structure or function of the body (structure/function claims), if certain requirements are met. The manufacturer of a dietary supplement containing a "structure/function" claim in the product's labeling must have substantiation that the claim is truthful and not misleading [21 U.S.C. 343(r)(6)(B)]

The labeling of your product "Chitorex™" bear structure/function claims about these products and their ingredients, including the following:

"Chitorex™ is a MECHANICAL" weight loss aid that absorbs 2000X it's weight in fat and converts it to a non-digestable gel that not only eliminates the fat makes you feel full for hours."

We have reviewed these claims and have concluded that they are not supported by reliable scientific evidence. Because these claims lack substantiation, they are false or misleading, and cause your products to be misbranded under sections 403(a)(1) and 403(r)6(B) of the Act [21 U.S.C. 343(a)(1), (r)(6)(B)].

In addition, the products, Digestrin™, Goutin™, Liporex™, Chitorex™, Zetacap™, Welatonin™ are misbranded under section 403(a)(1) of the Act in that its labeling is false or misleading [21 U.S.C. 343(a)(1)].

"Q: Is [Welatonin, Zetacap, Goutin, Disgestrin, Chitorex, Lipex] approved by FDA?" "A: The ingredients [in Welatonin, Zetacap, Goutin, Disgestrin, Chitorex, Lipex] have been given "GRASE" status by the US Food and Drug Administration (FDA) Generally recognized as safe and effective..."

These statements are false and misleading and misbrand the products Digestrin™, Goutin™, Liporex™, Chitorex™, Zetacap™, Welatonin™ under 403(a)(1) of the Act [21 U.S.C. 343(a)(1)] because they state that the ingedients contained in these products are generally recognized as safe and effective when, in fact they are not. Furthermore, they imply that FDA reviews and approves dietary supplement products and/or their ingredients. In fact, FDA does not approve dietary supplements or their ingredients.

Canthorex Product

Even if the labeling for Canthorex did not contain claims which cause it to be a drug, the product is an adulterated cosmetic. Your Internet web site promotes this product for coloring the skin. The Act defines the term "cosmetic" at section 201(i)(1) to include articles intended to be introduced into the human body for altering appearance [21 U.S.C. 321(i)(1)]. Even though your web site states that Canthorex™ capsules "are not sold as tanning pills", and are instead "sold as a skin care supplement" the following web site statements establish that Canthorex is intended for use to alter the skin color to stimulate a suntan:

The above claims and similar oral statements made on the web site's voice-over establish that the Canthorex you are currently marketing on your web site is intended to impart color to the skin, thus making it a cosmetic product.

The Act defines the term "color additive" at section 201(t)(1)(B) as a material which, when added or applied to a food, drug, or cosmetic, or to the human body or any part thereof, is capable (alone or through reaction with another substance) of impairing color thereto [21 U.S.C. 321(i)(1)(B)]. Canthaxanthin is a color additive. Color additives are deemed to be unsafe unless they are used in accordance with a color additive regulation that specifies the conditions under which the color additive may be safely used, including the purposes for which it may be used and the product category or categories to which it may added [section 721(a) of the Act; 21 U.S.C 379(a)].

There is no color additive regulation currently allowing for the use Canthaxanthin to impact color to the skin or, for that matter, for the use of Canthaxanthin in a cosmetic product for any purpose.

Based on the above, the Canthaxanthin product you are marketing on your web site is adulterated under section 601(e) of the Act [21 U.S.C. 361(e)], in that it bears or contains a color additive, namely Canthaxanthin, which is unsafe within the meaning of section 721(a) of the Act [21 U.S.C. 379(a)].

In addition, Canthorex is a misbranded cosmetic under section 602(a) of the Act in that its labeling is false or misleading [21 U.S.C. 362(a)]. We call your attention to the following web site exchange under common questions:

"Q: Is Cantohrex™ FDA approved?

A: The ingredients have been given "GRASE" status by the US Food and Drug Administration (FDA) 'Generally recognized as safe and effective."

This statement misbrands the product because it states that ingredients in Canthorex are generally recognized as safe and effective when, in fact, they are not. Furthermore, this exchange implies FDA approval (and safety) when, as have pointed out above, this is an unsafe use of the color additive, Canthaxanthin.

It is a violation of section 301(a) of the Act introduce or deliver for introduction into interstate commerce any food (including a dietary supplement) or cosmetic that is adulterated or misbranded [21 U.S.C. 331(a)]

This letter is not intended to be an all-inclusive review of your web site and products your firm markets. It is your responsibility to ensure that all products marketed by your firm comply with the Act and its implementing regulations.

Please advise this office, in writing and within fifteen (15) working days of the receipt of this letter, as to the specific steps you have taken to correct the violations noted above and to assure that similar violations do not occur.

If corrective actions cannot be completed within fifteen working days, state the reason for the delay and time within which the corrections will be completed. Your reply should be addressed to Compliance Officer Kristen L. Moe, 5100 Paint Branch Parkway, HFS-607, College Park, Maryland, 20740-3835.

 

Sincerely,
/s/
Joseph R. Baca
Director
Office of Compliance,
Center for Food Safety and Applied Nutrition

This page was posted on March 1, 2006.

Links to Recommended Companies